back

Medicare now covering genetic testing

Georgia CORE

Last month, the federal government announced that Medicare has broadened its guidelines to cover USFDA-approved or -cleared genetic testing for ovarian and breast cancer patients. Genetic testing (or Next Generation Sequencing as a diagnostic laboratory test) provides the most comprehensive genetic analysis of a patient’s cancer because it enables simultaneous detection of multiple types of genetic alterations. Now more Medicare patients will have access to these tests for managing other types of inherited cancers and to reduce mortality and improve health outcomes.

“Medicare has realized that genetics is transforming medicine,” said Georgia CORE’s oncology clinical nurse specialist, Alice Kerber. “Genetic testing provides valuable information to guide patients and physicians in developing a personalized treatment plan.”

More information is at cms.gov.

Media, News & Events

Georgia Cancer Trial Finders Provider Engagement Webinar

Join us for a 35-minute Georgia Cancer Trial Finders Provider Engagement Webinar on March 26 from 12:15–12:50 PM (ET) featuring Dr. Trevor Feinstein, Chief Medical Officer of Georgia CORE, and Dr. Crain Garrott, Past President of the Georgia Society of Clinical Oncology (GASCO).

Because many referrals to Georgia Cancer Trial Finders originate from clinical teams, increasing provider awareness of this res

3/13/2026

Clinical Trials, Doctors & Cancer Centers

Hearts Aligned Integrative Educational Conference

This gathering is more than a conference. It is a coming together of medical professionals, integrative practitioners, community leaders, sponsors, and advocates who believe cancer care should include the whole person — body, mind, and spirit. Together, we are creating space for education, empowerment, and expanded access to integrative services for cancer patients, survivors, and caregivers.

3/09/2026